- 38821-52-2Benzamide,N-[1-[2-(1H-indol-3-yl)ethyl]-4-piperidinyl]-, hydrochloride (1:1)
- 38821-53-35-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid, 7-[[(2R)-2-amino-2-(1,4-cyclohexadien-1-yl)acetyl]amino]-3-methyl-8-oxo-,(6R,7R)-
- 38822-56-96-AMINO-N-BETA-D-GALACTOPYRANOSYL HEXANAMIDE
- 38822-58-1N-(ε-N-Benzyloxycarbonylamino)caproyl)-β-D-galactopyranosylamine (contains approx 35% Ethanol)
- 38827-07-53-Cyclohexene-1-methanol,a,a,4-trimethyl-, titanium(4+) salt (4:1)
- 38829-39-9Furan,3-methyl-2-nitro-
- 3882-98-22-Thiazolamine,4,5-dihydro-, hydrochloride (1:1)
- 3882-99-34,4’-Cyclohexylidendianilin (S.Base)
- 38833-00-0Chromate(1-),bis[4-(hydroxy-kO)-3-[[2- (hydroxy-kO)-1-naphthalenyl]azo-kN1]- benzenesulfonamidato(2-)]-,hydrogen
- 3883-86-11,1'-Biphenyl,2,2',3,3',5,5',6,6'-octafluoro-
Hot Products
- 104987-11-3Tacrolimus
- 141-53-7Sodium formate
- 8001-54-5Quaternary ammonium compounds, alkylbenzyldimethyl, chlorides
- 9003-39-8Povidone
- 10161-34-9Trenbolone acetate
- 402957-28-2Telaprevir
- 68-19-9Cyanocobalamin
- 7631-86-9Silicon dioxide
- 302-79-4Tretinoin
- 77-92-9Citric acid
|
Basic Information |
|
Post buying leads |
|
Suppliers |
|
Cas Database |
| Name |
Carbidopa |
EINECS | 642-905-9 |
| CAS No. | 38821-49-7 | Density | 1.42 g/cm3 |
| PSA | 125.04000 | LogP | 0.97380 |
| Solubility | N/A | Melting Point |
N/A |
| Formula | C10H16N2O5 | Boiling Point | 528.7 °C at 760 mmHg |
| Molecular Weight | 244.247 | Flash Point | 273.5 °C |
| Transport Information | N/A | Appearance | N/A |
| Safety | Risk Codes | N/A | |
| Molecular Structure |
|
Hazard Symbols | N/A |
| Synonyms |
Benzenepropanoicacid, a-hydrazino-3,4-dihydroxy-a-methyl-, monohydrate, (S)-;Benzenepropanoic acid, a-hydrazino-3,4-dihydroxy-a-methyl-, monohydrate, (aS)- (9CI);Carbidopa monohydrate; |
Article Data | 3 |
Carbidopa Chemical Properties
Molecular Structure of Benzenepropanoic acid, a-hydrazinyl-3,4-dihydroxy-a-methyl-, hydrate (1:1), (aS)- (CAS NO.38821-49-7):
.jpg)
IUPAC Name: (2S)-3-(3,4-Dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoic acid hydrate
Molecular Weight: 244.24444 [g/mol]
Molecular Formula: C10H16N2O5
H-Bond Donor: 6
H-Bond Acceptor: 7
Density: 1.42 g/cm3
Flash Point: 273.5 °C
Enthalpy of Vaporization: 84.58 kJ/mol
Boiling Point: 528.7 °C at 760 mmHg
Vapour Pressure: 5.27E-12 mmHg at 25 °C
Classification Code: Anti-Dyskinesia Agents; Antiparkinson agents; Central Nervous System Agents; Dopamine agents; Drug / Therapeutic Agent; Enzyme inhibitors; Inhibitor [decarboxylase]; Neurotransmitter Agents
SMILES: O=C(O)C(NN)(Cc1cc(O)c(O)cc1)C.O
InChI: InChI=1/C10H14N2O4.H2O/c1-10(12-11,9(15)16)5-6-2-3-7(13)8(14)4-6;/h2-4,12-14H,5,11H2,1H3,(H,15,16);1H2
InChIKey: QTAOMKOIBXZKND-UHFFFAOYAT
Carbidopa Toxicity Data With Reference
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| mouse | LD50 | intraperitoneal | 148mg/kg (148mg/kg) | SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: ATAXIA | Toxicology and Applied Pharmacology. Vol. 29, Pg. 181, 1974. |
| mouse | LD50 | intravenous | 519mg/kg (519mg/kg) | SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE BEHAVIORAL: ATAXIA BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) | Toxicology and Applied Pharmacology. Vol. 29, Pg. 181, 1974. |
| mouse | LD50 | oral | 1750mg/kg (1750mg/kg) | SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: ATAXIA | Toxicology and Applied Pharmacology. Vol. 29, Pg. 181, 1974. |
| mouse | LD50 | subcutaneous | 4955mg/kg (4955mg/kg) | SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE BEHAVIORAL: ATAXIA SKIN AND APPENDAGES (SKIN): HAIR: OTHER | Sankyo Kenkyusho Nempo. Annual Report of Sankyo Research Laboratories. Vol. 28, Pg. 116, 1976. |
| rabbit | LD | intravenous | > 600mg/kg (600mg/kg) | BEHAVIORAL: ATAXIA LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION KIDNEY, URETER, AND BLADDER: HEMATURIA | Toxicology and Applied Pharmacology. Vol. 29, Pg. 181, 1974. |
| rat | LD50 | intraperitoneal | 352mg/kg (352mg/kg) | SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: ATAXIA | Toxicology and Applied Pharmacology. Vol. 29, Pg. 181, 1974. |
| rat | LD50 | oral | 4810mg/kg (4810mg/kg) | SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: ATAXIA | Toxicology and Applied Pharmacology. Vol. 29, Pg. 181, 1974. |
| rat | LD50 | subcutaneous | 3428mg/kg (3428mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES SKIN AND APPENDAGES (SKIN): HAIR: OTHER | Sankyo Kenkyusho Nempo. Annual Report of Sankyo Research Laboratories. Vol. 28, Pg. 116, 1976 |
Carbidopa Specification
Benzenepropanoic acid, a-hydrazinyl-3,4-dihydroxy-a-methyl-, hydrate (1:1), (aS)- (CAS NO.38821-49-7), its Synonyms are (-)-L-alpha-Hydrazino-3,4-dihydroxy-alpha-methylhydrocinnamic acid monohydrate ; Benzenepropanoic acid, alpha-hydrazino-3,4-dihydroxy-alpha-methyl-, monohydrate, (S)- ; Carbidopa hydrate ; Carbidopa-1-wasser ; Lodosyn ; S(-)-alpha-Hydrazino-3,4-dihydroxy-alpha-methylhydrocinnamic acid monohydrate ; Hydrocinnamic acid, (-)-L-alpha-hydrazino-3,4-dihydroxy-alpha-methyl-, monohydrate .
What can I do for you?
Get Best Price
